KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+0.13%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$181M
AUM Growth
+$181M
Cap. Flow
+$11.6M
Cap. Flow %
6.43%
Top 10 Hldgs %
90.13%
Holding
15
New
3
Increased
4
Reduced
7
Closed
1

Top Buys

1
SUPN icon
Supernus Pharmaceuticals
SUPN
$14.1M
2
GSK icon
GSK
GSK
$10.5M
3
AVDL
Avadel Pharmaceuticals
AVDL
$7.44M
4
UTHR icon
United Therapeutics
UTHR
$1.9M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
$1.72M

Top Sells

1
BIIB icon
Biogen
BIIB
$16.7M
2
EXEL icon
Exelixis
EXEL
$3.22M
3
CAH icon
Cardinal Health
CAH
$2.77M
4
ALKS icon
Alkermes
ALKS
$1M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$633K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$10.1B
$32.4M 17.93% 878,533 -87,333 -9% -$3.22M
UTHR icon
2
United Therapeutics
UTHR
$13.8B
$30.3M 16.74% 98,228 +6,171 +7% +$1.9M
CAH icon
3
Cardinal Health
CAH
$35.5B
$26M 14.38% 188,745 -20,100 -10% -$2.77M
SUPN icon
4
Supernus Pharmaceuticals
SUPN
$2.53B
$14.1M 7.82% +431,986 New +$14.1M
JAZZ icon
5
Jazz Pharmaceuticals
JAZZ
$7.75B
$12.5M 6.91% 100,703 -5,100 -5% -$633K
ENTA icon
6
Enanta Pharmaceuticals
ENTA
$180M
$11.7M 6.46% 2,116,586 -804 -0% -$4.44K
GSK icon
7
GSK
GSK
$79.9B
$10.5M 5.83% +272,000 New +$10.5M
INDV icon
8
Indivior
INDV
$3.03B
$9.2M 5.09% 965,368 +29,688 +3% +$283K
SNY icon
9
Sanofi
SNY
$121B
$8.27M 4.57% 149,096 -100 -0.1% -$5.55K
BNTX icon
10
BioNTech
BNTX
$24B
$7.97M 4.41% 87,563 -1,100 -1% -$100K
AVDL
11
Avadel Pharmaceuticals
AVDL
$1.43B
$7.44M 4.11% +950,000 New +$7.44M
ALKS icon
12
Alkermes
ALKS
$4.78B
$6.86M 3.79% 207,822 -30,314 -13% -$1M
VNDA icon
13
Vanda Pharmaceuticals
VNDA
$279M
$3.46M 1.91% 754,381 +375,619 +99% +$1.72M
MURA icon
14
Mural Oncology
MURA
$35.7M
$89K 0.05% 70,263 +100 +0.1% +$127
BIIB icon
15
Biogen
BIIB
$19.4B
– – -108,923 Closed -$16.7M